A sentence in the Results section of the abstract on page 14211accidentally reversed the intended meaning of the data comparisonfor the primary end points of the study. It should read, "Results:The efficacy end point (a composite of 30-day mortality, reinfarctionor refractory ischemia) was 12.2% with enoxaparin versus 16.0%with unfractionated heparin (p < 0.001); the combined endpoint of efficacy plus safety (a composite of 30-day mortality,reinfarction, refractory ischemia, intracranial hemorrhage [ICH]or major systemic bleeding) was 15.0% versus 18.0%, respectively(p = 0.003)."
REFERENCE
Armstrong PW, Chang WC, Wallentin L, et al. Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data. CMAJ 2006;174(10):1421-6.